Cripto-1 contributes to stemness in hepatocellular carcinoma by stabilizing Dishevelled-3 and activating Wnt/β-catenin pathway

[1]  Peng Zhang,et al.  Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma , 2017, Molecular Cancer.

[2]  Ranlu Liu,et al.  Cripto-1 promotes epithelial-mesenchymal transition in prostate cancer via Wnt/β-catenin signaling. , 2017, Oncology reports.

[3]  J. Xiong,et al.  AMPK activators suppress breast cancer cell growth by inhibiting DVL3-facilitated Wnt/β-catenin signaling pathway activity. , 2017, Molecular medicine reports.

[4]  M. Biffoni,et al.  Cripto is essential to capture mouse epiblast stem cell and human embryonic stem cell pluripotency , 2016, Nature Communications.

[5]  Jun Guo,et al.  MicroRNA-15b suppresses the growth and invasion of glioma cells through targeted inhibition of cripto-1 expression. , 2016, Molecular medicine reports.

[6]  Gang Luo,et al.  Helicobacter pylori upregulates Nanog and Oct4 via Wnt/β-catenin signaling pathway to promote cancer stem cell-like properties in human gastric cancer. , 2016, Cancer letters.

[7]  I. Ng,et al.  Sox9 confers stemness properties in hepatocellular carcinoma through Frizzled-7 mediated Wnt/β-catenin signaling , 2016, Oncotarget.

[8]  J. Xu,et al.  Elevated expression of Cripto-1 correlates with poor prognosis in hepatocellular carcinoma , 2015, Oncotarget.

[9]  I. Ng,et al.  TCGA whole-transcriptome sequencing data reveals significantly dysregulated genes and signaling pathways in hepatocellular carcinoma , 2015, Frontiers of Medicine.

[10]  I. Ng,et al.  Nuclear factor kappa B–mediated CD47 up‐regulation promotes sorafenib resistance and its blockade synergizes the effect of sorafenib in hepatocellular carcinoma in mice , 2015, Hepatology.

[11]  Lei Yu,et al.  MicroRNA-424 inhibits Akt3/E2F3 axis and tumor growth in hepatocellular carcinoma , 2015, Oncotarget.

[12]  M. Todaro,et al.  Dynamic regulation of the cancer stem cell compartment by Cripto-1 in colorectal cancer , 2015, Cell Death and Differentiation.

[13]  B. Han,et al.  Wnt signaling regulates the stemness of lung cancer stem cells and its inhibitors exert anticancer effect on lung cancer SPC-A1 cells , 2015, Medical Oncology.

[14]  Wei Liu,et al.  MicroRNA-195 functions as a tumor suppressor by inhibiting CBX4 in hepatocellular carcinoma. , 2015, Oncology reports.

[15]  Li-ke Yu,et al.  Elevated expression of Cripto-1 correlates with poor prognosis in non-small cell lung cancer , 2014, Tumor Biology.

[16]  H. Fan,et al.  MiR-15a-16 represses Cripto and inhibits NSCLC cell progression , 2014, Molecular and Cellular Biochemistry.

[17]  Miran Kim,et al.  Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugs. , 2013, Journal of hepatology.

[18]  I. Ng,et al.  Liver tumor-initiating cells as a therapeutic target for hepatocellular carcinoma. , 2013, Cancer letters.

[19]  Jixiang Ding,et al.  Cripto is required for mesoderm and endoderm cell allocation during mouse gastrulation. , 2013, Developmental biology.

[20]  Yan Li,et al.  NANOG promotes liver cancer cell invasion by inducing epithelial-mesenchymal transition through NODAL/SMAD3 signaling pathway. , 2013, The international journal of biochemistry & cell biology.

[21]  I. Ng,et al.  Hepatic progenitor cells: their role and functional significance in the new classification of primary liver cancers. , 2013, Liver cancer.

[22]  M. Esteller,et al.  Epigenetic alterations involved in cancer stem cell reprogramming , 2012, Molecular oncology.

[23]  I. Ng,et al.  Upregulation of the Wnt Co-Receptor LRP6 Promotes Hepatocarcinogenesis and Enhances Cell Invasion , 2012, PloS one.

[24]  Jian-Rong Yang,et al.  MicroRNA-26a/b and their host genes cooperate to inhibit the G1/S transition by activating the pRb protein , 2011, Nucleic acids research.

[25]  Peng Cheng,et al.  Nanog and β-catenin: A new convergence point in EpSC proliferation and differentiation , 2011, International journal of molecular medicine.

[26]  Hong Peng,et al.  Interactions between cancer stem cells and their niche govern metastatic colonization , 2011, Nature.

[27]  R. Yang,et al.  Let-7c MicroRNA Expression and Clinical Significance in Hepatocellular Carcinoma , 2011, The Journal of international medical research.

[28]  Hongyue Dai,et al.  Clinicopathological and prognostic significance of serum and tissue Dickkopf‐1 levels in human hepatocellular carcinoma , 2011, Liver international : official journal of the International Association for the Study of the Liver.

[29]  C. Moskaluk,et al.  Integrated, Genome-Wide Screening for Hypomethylated Oncogenes in Salivary Gland Adenoid Cystic Carcinoma , 2011, Clinical Cancer Research.

[30]  M. Chevallier,et al.  Pharmacological inhibition of Frizzled-7 displays anti-tumor properties in hepatocellular carcinoma. , 2011, Journal of hepatology.

[31]  Satdarshan P. S. Monga,et al.  Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad. , 2011, Seminars in cancer biology.

[32]  Y. Shin,et al.  Epigenetic Regulation of Cancer-Associated Genes in Ovarian Cancer , 2011, International journal of molecular sciences.

[33]  Maria Cristina Rangel,et al.  Role of Cripto-1 in stem cell maintenance and malignant progression. , 2010, The American journal of pathology.

[34]  M. Hendrix,et al.  Cripto‐1 Is a Cell Surface Marker for a Tumorigenic, Undifferentiated Subpopulation in Human Embryonal Carcinoma Cells , 2010, Stem cells.

[35]  S. Thorgeirsson,et al.  Stem Cells in Hepatocarcinogenesis: Evidence from Genomic Data , 2010, Seminars in liver disease.

[36]  M. Ehrlich.  DNA hypomethylation in cancer cells. , 2009, Epigenomics.

[37]  K. Yao,et al.  Cripto-1 overexpression is involved in the tumorigenesis of nasopharyngeal carcinoma , 2009, BMC Cancer.

[38]  Liang Tang,et al.  Wnt/beta-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells. , 2008, Cancer research.

[39]  A-P Lu,et al.  Positive association of up‐regulated Cripto‐1 and down‐regulated E‐cadherin with tumour progression and poor prognosis in gastric cancer , 2008, Histopathology.

[40]  Xin Wei Wang,et al.  Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma. , 2007, Cancer research.

[41]  J. McNamara.  Cancer Stem Cells , 2007, Methods in Molecular Biology.

[42]  M. Katoh,et al.  WNT Signaling Pathway and Stem Cell Signaling Network , 2007, Clinical Cancer Research.

[43]  C. Kennedy,et al.  Overexpression of Cripto and its prognostic significance in breast cancer: a study with long-term survival. , 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[44]  C. Bianco,et al.  beta-Catenin/TCF/LEF regulate expression of the short form human Cripto-1. , 2007, Biochemical and biophysical research communications.

[45]  I. Ng,et al.  Prickle-1 negatively regulates Wnt/beta-catenin pathway by promoting Dishevelled ubiquitination/degradation in liver cancer. , 2006, Gastroenterology.

[46]  S. D. L. Monte,et al.  Oncogenic role of the frizzled-7/β-catenin pathway in hepatocellular carcinoma , 2005 .

[47]  Miran Kim,et al.  Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma. , 2004, Gastroenterology.

[48]  G. Minchiotti,et al.  Role of the EGF-CFC gene cripto in cell differentiation and embryo development. , 2002, Gene.

[49]  S. Fan,et al.  β‐catenin mutation and overexpression in hepatocellular carcinoma , 2001 .

[50]  A. Wynshaw-Boris,et al.  Cripto is required for correct orientation of the anterior–posterior axis in the mouse embryo , 1998, Nature.

[51]  N. Normanno,et al.  Differential immunohistochemical detection of amphiregulin and cripto in human normal colon and colorectal tumors. , 1992, Cancer research.

[52]  D. Salomon,et al.  Differential expression of epidermal growth factor-related proteins in human colorectal tumors. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[53]  Silvana,et al.  Molecular characterization of a gene of the ‘EGF family’ expressed in undifferentiated human NTERA2 teratocarcinoma cells. , 1989, The EMBO journal.

[54]  S. Lockett,et al.  Cripto-1 enhances the canonical Wnt/β-catenin signaling pathway by binding to LRP5 and LRP6 co-receptors. , 2013, Cellular signalling.

[55]  Miran Kim,et al.  Oncogenic role of the frizzled-7/beta-catenin pathway in hepatocellular carcinoma. , 2005, Journal of hepatology.

[56]  S. Fan,et al.  beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance. , 2001, Cancer.